Delivery Order SPE2DB22D1106-SPE2DB25FFHB5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,305.13 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes. The award, issued on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,222.90 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ovidrel 250 mcg/0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a single-line delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same municipality. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for OVIDREL 250 MCG/0.5 ML syringes valued at $1,259.20 with a firm fixed price structure. The award, issued on July 26, 2025, is a non-set-aside competitive contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office operations serving federal medical...
- The Defense Logistics Agency awarded a $2,723.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561401606 Ovidrel 250 mcg/0.5 ml syringes. The delivery order, issued under an existing prime vendor contract vehicle, calls for the delivery of 0.5 ml syringes of Ovidrel, a gonadotropin-releasing hormone drug used to induce ovulation, to a Defense Logistics Agency location in Conshohocken, Pennsylvania. The delivery order period of performance spans from...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,551.60, is a delivery order for OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $113,490 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562052088 Ovidrel 250 mcg/0.5 ml syrg 0.5ml. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. As a prime contractor supporting DLA Troop Support Medical, Amerisourcebergen will deliver fertility drug Ovidrel to aid the Defense Health Agency in fulfilling prescription needs for military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,499.20 order is for the supply of the medication OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a performance period through March 26, 2024. Amerisourcebergen Drug Corporation is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.15 firm fixed price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The $4,201.80 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance period ending on July 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $145.89 delivery order to Amerisourcebergen Drug Corp for the purchase of 4562345634 OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The firm fixed price order is being fulfilled under Amerisourcebergen's corporate office division and will be performed in Conshohocken, Pennsylvania over a one day period from September 28 through September 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHB5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,765.72 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes with a completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing for the pharmaceutical product delivery, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. This delivery order for Ovidrel, a fertility hormone medication, exemplifies the company's role in supplying specialized pharmaceuticals across multiple therapeutic domains to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/5/25 |